Swiss-Chinese Life Sciences Forum 2026

The Swiss-Chinese Life Sciences Forum 2026 convenes decision-makers, researchers, and professional advisors to evaluate the shifting dynamics of bilateral healthcare innovation. As cross-border ties expand from conventional distribution to novel licensing, co-development, and joint investment, this forum offers a roadmap for strategic cooperation.

Participants will examine the practical and regulatory steps needed to build resilient partnerships across jurisdictions, supported by firsthand insights from corporate leaders and advisory specialists.

What to expect

• Strategic analysis of biotech deal flows and licensing trends connecting Switzerland and China
• Deep dive into multinational perspectives and real-world execution case studies
• Interactive panel discussion with industry veterans and professional advisors
• Informal networking apéro to establish bilateral business relationships

Speakers

Hong ShenSenior Vice President and Head of the China Innovation Center at RocheVincent S. ReardonPartner at VISCHERMaurice PerrinjaquetPartner, Life Sciences Strategy at EYZoe Qianhua XiongSenior Manager, Strategy and Transactions at EY-ParthenonHubert StadlerPartner, International Tax and Transfer Pricing at EYGabriel SchweizerHead of Foreign Trade Policy and Life Sciences at Basel Chamber of CommerceLukas ZüstPartner and Head of China Desk at VISCHER

Kewei YangSenior Director, CMC Lead at WuXi Biologics

Show 6 moreShow 5 more

Agenda

1. 08:30 Registration Guest arrival and check-in 2. 09:00 Welcome Opening remarks by the Swiss-Chinese Chamber of Commerce 3. 09:05 Life Sciences Market & Deal Outlook: China and Global Trends Analysis of market momentum and strategic transactions 4. 09:25 Evolution of China Biotech's out-licensing Industry overview of expanding global pipeline assets 5. 09:45 The Strategic Imperative: Harnessing China's Ecosystem - an MNC's perspective Keynote insights on regional healthcare opportunities 6. 10:05 From Strategy to Execution: A Cross-Border Life Sciences Case Study Legal, strategic, and tax execution lessons 7. 10:25 Break Coffee and informal exchange 8. 10:45 Panel Discussion Multi-stakeholder debate featuring corporate and advisory experts 9. 11:30 Closing Summary of forum takeaways 10. 11:35 Networking Apéro Reception and continued conversations

Who should attend

This event is tailored for senior executives, business development managers, legal counsel, and investors active in biotechnology, pharmaceuticals, and cross-border healthcare transactions.

About the host

The Swiss-Chinese Chamber of Commerce serves as a key bridge fostering economic relations, investment opportunities, and bilateral knowledge exchange between Switzerland and China.